Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

被引：0
|
作者：
Vincent Walter
Chiara Fischer
Thomas M. Deutsch
Catherine Ersing
Juliane Nees
Florian Schütz
Carlo Fremd
Eva-Maria Grischke
Peter Sinn
Sara Y. Brucker
Andreas Schneeweiss
Andreas D. Hartkopf
Markus Wallwiener
机构：
[1] University Hospital Tuebingen,Department of Obstetrics and Gynecology
[2] University Hospital Heidelberg,Department of Obstetrics and Gynecology
[3] National Center for Tumor Diseases (NCT),Division of Gynecologic Oncology
[4] German Cancer Research Center,Department of Pathology
[5] University Hospital Heidelberg,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 183卷
关键词：
Metastatic breast cancer; Receptor status discordance; Distant metastasis; Estrogen receptor (ER); Progesterone receptor (PR); Human epidermal growth factor receptor 2 (HER2);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 144
页数：7
相关论文
共 50 条
  • [1] Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
    Walter, Vincent
    Fischer, Chiara
    Deutsch, Thomas M.
    Ersing, Catherine
    Nees, Juliane
    Schuetz, Florian
    Fremd, Carlo
    Grischke, Eva-Maria
    Sinn, Peter
    Brucker, Sara Y.
    Schneeweiss, Andreas
    Hartkopf, Andreas D.
    Wallwiener, Markus
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 137 - 144
  • [2] A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
    Aurilio, Gaetano
    Disalvatore, Davide
    Pruneri, Giancarlo
    Bagnardi, Vincenzo
    Viale, Giuseppe
    Curigliano, Giuseppe
    Adamoli, Laura
    Munzone, Elisabetta
    Sciandivasci, Angela
    De Vita, Fernando
    Goldhirsch, Aron
    Nole, Franco
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) : 277 - 289
  • [3] Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer
    VanAgthoven, T
    Timmermans, M
    Dorssers, LCJ
    HenzenLogmans, SC
    INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (06) : 790 - 793
  • [4] Advances in Variations of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor-2 Status in Metastatic Breast Cancer
    Yuan Yuan
    Zhang Lili
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (02): : 55 - 60
  • [5] DISCORDANCE OF HORMONE RECEPTOR AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR2 AS A PROGNOSTIC FACTOR OF SURVIVAL BETWEEN PRIMARY BREAST CANCER AND RECURRENT BREAST CANCER
    Kim, Euitae
    BREAST, 2017, 36 : S64 - S64
  • [6] Expression of Estrogen, Progesterone Receptors, and Human Epidermal Growth Factor Receptor 2 in Women With Breast Cancer
    Mlole, Angela
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 : S89 - S89
  • [7] Is there any associaton between disease-free interval and discordant rates in estrogen, progesterone, and human epidermal growth factor receptor 2 status between primary and metastatic breast cancer?
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (04): : 2131 - 2131
  • [8] Discordance in estrogen receptor, progesterone receptor and HER-2/neu status between primary and metastatic breast cancer: A systematic review
    Yeung, I. C.
    Clemons, M.
    Haggar, F.
    Addison, C.
    Hutton, B.
    Kuchuk, I.
    Zhu, X.
    Mazzarello, S.
    Arnaout, A.
    CANCER RESEARCH, 2013, 73
  • [9] Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
    Panahi, Marzieh
    Saki, Najmaldin
    Ashourzadeh, Sara
    Rahim, Fakher
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3699 - 3703
  • [10] Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review
    C. Yeung
    J. Hilton
    M. Clemons
    S. Mazzarello
    B. Hutton
    F. Haggar
    C. L. Addison
    I. Kuchuk
    X. Zhu
    K. Gelmon
    A. Arnaout
    Cancer and Metastasis Reviews, 2016, 35 : 427 - 437
12345